18 Sep 2023 --- UK-based life science business SkinBioTherapeutics has secured approval from the French health authorities and plans to begin advertising its food supplement AxisBiotix-Ps in France this October. The product is designed to alleviate symptoms related to the common skin condition Psoriasis, which affects 2 to 3% of the global population and an estimated 2 million French residents. Launching the product in France will generate an additional geographical revenue stream for the company. The exact date has yet to be announced.
